Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's Global Life Sciences Conference March 9-10, 2021
Arcadia Biosciences (Nasdaq: RKDA) announced its participation in the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Arcadia Biosciences (Nasdaq: RKDA) announced its participation in the H.C. Wainwright Global Life Sciences Conference scheduled for March 9-10, 2021. The company aims to showcase its innovative approaches to enhancing crop quality and nutritional value through scientific methods. President and CEO Matt Plavan will provide an overview of the business and engage in one-on-one meetings with investors. The presentation will be available on-demand starting March 9 at 7:00 AM (EST) and will include a replay accessible via the company’s website.
Details
News Market Reaction – RKDA
The recorded move for RKDA in the trading session of this news was -1.23%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DAVIS, Calif., March 2, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be presenting at the H.C. Wainwright Global Life Sciences Conference. The conference will be held virtually March 9-10, 2021.
Matt Plavan, Arcadia's president and CEO will present an overview of the company's business and will be available for one-on-one web meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hcwevents.com/globalconference.
The presentation will be available on-demand here starting on March 9 at 7:00 AM (EST). A replay will be available in the Investors section of the company's website.
About Arcadia Biosciences
Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients. The company's GoodHemp™ seed catalog delivers genetically superior hemp seeds, transplants and extracts, applying the company's proprietary crop innovation technology, ArcaTech™, to an emerging crop. The company's GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. For more information, visit www.arcadiabio.com.
Arcadia Biosciences Contact:
Pam Haley
ir@arcadiabio.com
LinkedIn: Arcadia Biosciences
Twitter: @ArcadiaAg
View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-to-present-at-hc-wainwrights-global-life-sciences-conference-march-9-10-2021-301238350.html
SOURCE Arcadia Biosciences, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.